Citation Impact
Citing Papers
Outcomes in refractory diffuse large B-cell lymphoma: results from the international SCHOLAR-1 study
2017 Standout
Histone demethylase KDM6A directly senses oxygen to control chromatin and cell fate
2019 StandoutScienceNobel
Inhibition of PRC2 Activity by a Gain-of-Function H3 Mutation Found in Pediatric Glioblastoma
2013 Science
LncRNA HOXA11-AS Promotes Proliferation and Invasion of Gastric Cancer by Scaffolding the Chromatin Modification Factors PRC2, LSD1, and DNMT1
2016 Standout
The 2016 revision of the World Health Organization classification of lymphoid neoplasms
2016 Standout
Evolution of the Cancer Stem Cell Model
2014 Standout
PD-1 expression by tumour-associated macrophages inhibits phagocytosis and tumour immunity
2017 StandoutNature
The EGLN-HIF O 2 -Sensing System: Multiple Inputs and Feedbacks
2017 StandoutNobel
dCas9 fusion to computer-designed PRC2 inhibitor reveals functional TATA box in distal promoter region
2022 StandoutNobel
The molecular hallmarks of epigenetic control
2016 Standout
Functions of DNA methylation: islands, start sites, gene bodies and beyond
2012 Standout
Oncology Meets Immunology: The Cancer-Immunity Cycle
2013 Standout
Therapeutic modulation of Notch signalling — are we there yet?
2014
PRC2 is high maintenance
2019
Cancer Stem Cells: Impact, Heterogeneity, and Uncertainty
2012 Standout
Precision therapy for lymphoma—current state and future directions
2014
Epigenetics and the environment: emerging patterns and implications
2012 Standout
Approaches to treat immune hot, altered and cold tumours with combination immunotherapies
2019 Standout
Allosteric Activation Dictates PRC2 Activity Independent of Its Recruitment to Chromatin
2018
The Role of the Histone Methyltransferase Enhancer of Zeste Homolog 2 (EZH2) in the Pathobiological Mechanisms Underlying Inflammatory Bowel Disease (IBD)
2016
Turning tumour cells into antigen presenting cells: The next step to improve cancer immunotherapy?
2016
Cancer Epigenetics: From Mechanism to Therapy
2012 Standout
Hypomethylating agents in combination with immune checkpoint inhibitors in acute myeloid leukemia and myelodysplastic syndromes
2018 StandoutNobel
Cancer stem cells revisited
2017 Standout
Hypoxia increases genome-wide bivalent epigenetic marking by specific gain of H3K27me3
2016
Tumor-Associated Macrophages: From Mechanisms to Therapy
2014 Standout
Nivolumab in metastatic urothelial carcinoma after platinum therapy (CheckMate 275): a multicentre, single-arm, phase 2 trial
2017 Standout
Current and future perspectives of liquid biopsies in genomics-driven oncology
2018 Standout
A protein-interaction network of interferon-stimulated genes extends the innate immune system landscape
2019 StandoutNobel
The CCR4-NOT complex contributes to repression of Major Histocompatibility Complex class II transcription
2017
Therapeutic antibodies for autoimmunity and inflammation
2010
A microRNA-mediated regulatory loop modulates NOTCH and MYC oncogenic signals in B- and T-cell malignancies
2014
Antibody therapy of cancer
2012 Standout
The hypoxic tumor microenvironment: A driving force for breast cancer progression
2015 StandoutNobel
The Genetic Landscape of Diffuse Large B-Cell Lymphoma
2015
Immune Checkpoint Targeting in Cancer Therapy: Toward Combination Strategies with Curative Potential
2015 StandoutNobel
Role of the Polycomb Repressive Complex 2 (PRC2) in Transcriptional Regulation and Cancer
2016
Epigenetic Control of Immunity
2014
Targeting apoptosis in cancer therapy
2020 Standout
Automethylation of PRC2 promotes H3K27 methylation and is impaired in H3K27M pediatric glioma
2019
Recurrent loss of heterozygosity in 1p36 associated with TNFRSF14 mutations in IRF4 translocation negative pediatric follicular lymphomas
2013
MicroRNA biogenesis pathways in cancer
2015 Standout
Epigenetic protein families: a new frontier for drug discovery
2012
Silencing of Kruppel-like factor 2 by the histone methyltransferase EZH2 in human cancer
2011
Proteomic and bioinformatic analysis of mammalian SWI/SNF complexes identifies extensive roles in human malignancy
2013 Standout
TET enzymes, TDG and the dynamics of DNA demethylation
2013 StandoutNature
Regulation and Function of the PD-L1 Checkpoint
2018 Standout
Mechanism-driven biomarkers to guide immune checkpoint blockade in cancer therapy
2016 Standout
MDM2/X inhibitors under clinical evaluation: perspectives for the management of hematological malignancies and pediatric cancer
2017
MicroRNA therapeutics: towards a new era for the management of cancer and other diseases
2017 Standout
Primary, Adaptive, and Acquired Resistance to Cancer Immunotherapy
2017 Standout
Analysis of the coding genome of diffuse large B-cell lymphoma
2011
Diffuse large B-cell lymphoma—treatment approaches in the molecular era
2013
Driver mutations of cancer epigenomes
2014
Histone Modifications and Cancer
2016
Modulation of EZH2 expression in T cells improves efficacy of anti–CTLA-4 therapy
2018 StandoutNobel
Early lesions of follicular lymphoma: a genetic perspective
2013
Strategies and challenges for the next generation of antibody–drug conjugates
2017 Standout
Hypoxia promotes stem cell phenotypes and poor prognosis through epigenetic regulation of DICER
2014
Implications of the tumor immune microenvironment for staging and therapeutics
2017
A decade of exploring the cancer epigenome — biological and translational implications
2011 Standout
Immune Checkpoint Blockade: A Common Denominator Approach to Cancer Therapy
2015 Standout
A guide to cancer immunotherapy: from T cell basic science to clinical practice
2020 Standout
EZH2 Codon 641 Mutations are Common in BCL2-Rearranged Germinal Center B Cell Lymphomas
2011
Molecular pathogenesis of mantle cell lymphoma
2012
Astemizole Arrests the Proliferation of Cancer Cells by Disrupting the EZH2-EED Interaction of Polycomb Repressive Complex 2
2014
Flow sorting and exome sequencing reveal the oncogenome of primary Hodgkin and Reed-Sternberg cells
2014
Array comparative genomic hybridization reveals similarities between nodular lymphocyte predominant Hodgkin lymphoma and T cell/histiocyte rich large B cell lymphoma
2015
DNA methylation in the central and efferent limbs of the chemoreflex requires carotid body neural activity
2017 StandoutNobel
Recent advances in understanding the molecular pathogenesis of myelodysplastic syndromes
2013
PD-L1 (B7-H1) and PD-1 pathway blockade for cancer therapy: Mechanisms, response biomarkers, and combinations
2016 Standout
The role of B7 family molecules in hematologic malignancy
2012
Exosomal evasion of humoral immunotherapy in aggressive B-cell lymphoma modulated by ATP-binding cassette transporter A3
2011
Diffuse large B-cell lymphoma: optimizing outcome in the context of clinical and biologic heterogeneity
2014
The biology , function , and biomedical applications of exosomes
2020 StandoutScience
The future of immune checkpoint therapy
2015 StandoutScienceNobel
The Versatile Role of microRNA-30a in Human Cancer
2017 Standout
Single-Cell Mass Cytometry of Differential Immune and Drug Responses Across a Human Hematopoietic Continuum
2011 StandoutScience
Cancer Genome Landscapes
2013 StandoutScience
Clonal expansion of CD8 T cells in the systemic circulation precedes development of ipilimumab-induced toxicities
2016 StandoutNobel
Clonal hematopoiesis of indeterminate potential and its distinction from myelodysplastic syndromes
2015 Standout
PD-1 Blockade with Nivolumab in Relapsed or Refractory Hodgkin's Lymphoma
2014 Standout
Cancer immunotherapy using checkpoint blockade
2018 StandoutScience
B-cell signaling networks reveal a negative prognostic human lymphoma cell subset that emerges during tumor progression
2010
Integrative analysis reveals selective 9p24.1 amplification, increased PD-1 ligand expression, and further induction via JAK2 in nodular sclerosing Hodgkin lymphoma and primary mediastinal large B-cell lymphoma
2010
PD-L1 and PD-L2 Genetic Alterations Define Classical Hodgkin Lymphoma and Predict Outcome
2016
Works of Merrill Boyle being referenced
Genomic Alterations in CIITA Are Frequent in Primary Mediastinal Large B Cell Lymphoma and Are Associated with Diminished MHC Class II Expression
2015
Genome-wide copy number analysis of Hodgkin Reed-Sternberg cells identifies recurrent imbalances with correlations to treatment outcome
2010
High resolution analysis of follicular lymphoma genomes reveals somatic recurrent sites of copy‐neutral loss of heterozygosity and copy number alterations that target single genes
2010
Diffuse large B-cell lymphoma: reduced CD20 expression is associated with an inferior survival
2008
Whole transcriptome sequencing reveals recurrent NOTCH1 mutations in mantle cell lymphoma
2011
Somatic mutations at EZH2 Y641 act dominantly through a mechanism of selectively altered PRC2 catalytic activity, to increase H3K27 trimethylation
2010